InnovAge Holding (INNV) Cash & Equivalents (2020 - 2026)

InnovAge Holding has reported Cash & Equivalents for 7 years, with the latest figure at $95.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 58.03% year-over-year to $95.5 million; the trailing twelve-month figure through Mar 2026 stood at $95.5 million (up 58.03% YoY), and the FY2025 full-year result was $64.1 million, up 12.61% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $95.5 million, up from $83.2 million in the prior quarter.
• The five-year high for Cash & Equivalents was $199.5 million in Q1 2022, with the low at $39.0 million in Q3 2024.
• Historically, Cash & Equivalents has averaged $95.9 million across 5 years, with a median of $83.2 million in 2025.
• Annual changes were most pronounced in 2024 — Cash & Equivalents sank 55.86% — and 2025, when it jumped 80.57%.
• InnovAge Holding's Cash & Equivalents stood at $99.5 million in 2022, then slumped by 45.63% to $54.1 million in 2023, then retreated by 14.8% to $46.1 million in 2024, then jumped by 80.57% to $83.2 million in 2025, then increased by 14.82% to $95.5 million in 2026.
• The last three Cash & Equivalents figures came in at $95.5 million (Q1 2026), $83.2 million (Q4 2025), and $67.1 million (Q3 2025), per Business Quant data.